Press release
Human Papillomavirus Market Set for Breakthrough Expansion by 2034, Driven by Innovations from Inovio, ISA Pharmaceuticals, Merck, Regeneron, and More - DelveInsight
Human Papillomavirus Market
DelveInsight's "Human Papillomavirus - Market Insight, Epidemiology, And Market Forecast - 2034′′ report offers an in-depth understanding of the human papillomavirus, historical and forecasted epidemiology as well as the human papillomavirus market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Some of the key facts of the Human Papillomavirus Market Report:
• According to DelveInsight, the human papillomavirus market in the 7MM is expected to experience significant growth during the study period from 2020 to 2034.
• According to the CDC, HPV is the most common sexually transmitted infection in the United States, with an oral HPV prevalence of 7.3% and high-risk HPV at 4.0% among adults aged 18-69 during 2011-2014.
• A study by Han et al. (2017) found that genital HPV infection affected 45.2% of men in the NHANES 2013-2014 survey, with low HPV vaccination rates of 10.7%.
• Available literature indicates that genital HPV prevalence is higher in men than in women.
• In February 2025, Precigen, Inc. announced that the FDA accepted its biologics license application (BLA) for PRGN-2012, an investigational gene therapy designed to treat HPV 6 and HPV 11-associated recurrent respiratory papillomatosis (RRP). The therapy received priority review, with a PDUFA date set for August 27, 2025.
• PRGN-2012 is designed to elicit immune responses against HPV-infected cells and has received Breakthrough Therapy Designation, Orphan Drug Designation, and an accelerated approval pathway from the FDA.
• In May 2024, Roche received FDA approval for its HPV self-testing kit, enabling early detection and improved diagnosis of HPV-related diseases.
• Key therapies in development for HPV include STP909, RTX-321, BVAC-C, GX-188E, ITI-2000, VGX-3100, ISA101, and others.
• Leading companies in the HPV treatment landscape include Inovio Pharmaceuticals, ISA Pharmaceuticals, Regeneron Pharmaceuticals, Merck, Pattern Pharma, Nykode, Vaccibody A/S, Turnstone Biologics, Advaxis, AstraZeneca, VLP The Vaccines Company SL, Voltron Therapeutics Inc., Rubius Therapeutics, Bristol-Myers Squibb, Precigen Inc., Privo Technologies, ViciniVax BV, Avalia Immunotherapies, BlueSky Immunotherapies, Cellid Co. Ltd, Cue Biopharma, Cullinan Oncology, Genexine, EyeGene, Hookipa Pharma, Immunomic Therapeutics, SQZ Biotechnologies, and others.
Request a sample to explore key market trends and future opportunities in the evolving human papillomavirus landscape across the 7MM @ https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Human Papillomavirus Overview
Human Papillomavirus (HPV) is a group of more than 200 related viruses, many of which can infect the skin and mucous membranes. Some strains of HPV can lead to benign warts, while others are associated with various cancers, including cervical, anal, and oropharyngeal cancers. HPV is primarily transmitted through sexual contact and is one of the most common sexually transmitted infections worldwide. Although most infections are asymptomatic and clear on their own, persistent infection with high-risk HPV types can lead to cancer. Vaccination and screening are key strategies in preventing HPV-related cancers.
Human Papillomavirus Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Download the report to understand which factors are driving human papillomavirus epidemiology trends @ https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Human Papillomavirus Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Human Papillomavirus market or expected to be launched during the study period. The analysis covers the Human Papillomavirus market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the human papillomavirus pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
To know in detail about the human papillomavirus market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Human Papillomavirus Market Strengths
• The availability of HPV vaccines, such as Gardasil, which offer protection against the most dangerous strains of the virus, is a significant strength in managing and preventing HPV-related diseases.
• Growing public health awareness about HPV's role in cancer prevention and the benefits of vaccination has led to higher vaccination rates, particularly among adolescents.
Human Papillomavirus Market Weaknesses
• Despite the effectiveness of vaccines, there are still regions, particularly in low- and middle-income countries, where access to HPV vaccination remains limited due to cost and infrastructure challenges.
• The stigma surrounding sexually transmitted infections like HPV can hinder individuals from seeking vaccination or screening, leading to lower prevention rates and delayed diagnoses.
Get a free sample for the human papillomavirus market Report: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Scope of the Human Papillomavirus Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Human Papillomavirus Therapies: STP909, RTX-321, BVAC-C, GX-188E, ITI-2000, VGX-3100, ISA101, and others.
• Key Human Papillomavirus Companies: Inovio Pharmaceuticals, ISA Pharmaceuticals, Regeneron Pharmaceuticals, Merck, Pattern Pharma, Nykode, Vaccibody A/S, Turnstone Biologics, Advaxis, AstraZeneca, VLP The Vaccines Company SL, Voltron Therapeutics Inc., Rubius Therapeutics, Bristol-Myers Squibb, Precigen Inc., Privo Technologies, ViciniVax BV, Avalia Immunotherapies, BlueSky Immunotherapies, Cellid Co. Ltd, Cue Biopharma, Cullinan Oncology, Genexine, EyeGene, Hookipa Pharma, Immunomic Therapeutics, SQZ Biotechnologies, and others.
• Human Papillomavirus Therapeutic Assessment: Human Papillomavirus currently marketed and Human Papillomavirus emerging therapies
• Human Papillomavirus Market Dynamics: Human Papillomavirus market drivers and Human Papillomavirus market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Human Papillomavirus Unmet Needs, KOL's views, Analyst's views, Human Papillomavirus Market Access and Reimbursement
To learn more about the key players and advancements in the human papillomavirus treatment Landscape, visit: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. Human Papillomavirus Market Report Introduction
2. Executive Summary for Human Papillomavirus
3. SWOT analysis of Human Papillomavirus
4. Human Papillomavirus Patient Share (%) Overview at a Glance
5. Human Papillomavirus Market Overview at a Glance
6. Human Papillomavirus Disease Background and Overview
7. Human Papillomavirus Epidemiology and Patient Population
8. Country-Specific Patient Population of Human Papillomavirus
9. Human Papillomavirus Current Treatment and Medical Practices
10. Human Papillomavirus Unmet Needs
11. Human Papillomavirus Emerging Therapies
12. Human Papillomavirus Market Outlook
13. Country-Wise Human Papillomavirus Market Analysis (2020-2034)
14. Human Papillomavirus Market Access and Reimbursement of Therapies
15. Human Papillomavirus Market Drivers
16. Human Papillomavirus Market Barriers
17. Human Papillomavirus Appendix
18. Human Papillomavirus Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform, PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Papillomavirus Market Set for Breakthrough Expansion by 2034, Driven by Innovations from Inovio, ISA Pharmaceuticals, Merck, Regeneron, and More - DelveInsight here
News-ID: 3986203 • Views: …
More Releases from DelveInsight
Transradial Access Products Market to Register a CAGR of 7.20% by 2032, Driven b …
The transradial access products market is expected to experience steady growth, fueled by the increasing adoption of transradial access in coronary angiography and percutaneous coronary interventions due to lower complication rates, faster recovery, and improved patient comfort compared to transfemoral approaches. Advancements in radial sheaths, catheters, and hemostasis devices are enhancing procedural safety and success rates, further supporting clinical preference for the radial route. In addition, the growing global cardiovascular…
Spinal Fusion Devices Market to Register a CAGR of 5.31% by 2032, Driven by Risi …
The spinal fusion devices market is expected to witness robust growth, fueled by the increasing prevalence of degenerative spinal disorders, trauma cases, and the growing aging population worldwide. Advancements in minimally invasive spine surgery, the development of motion-preserving technologies, and the adoption of biocompatible materials are significantly improving patient outcomes and reducing recovery times.
Furthermore, the integration of navigation systems, robotics, and 3D printing is enhancing surgical precision and implant…
Spinal Cord Stimulators Market to Register a CAGR of 9.83% by 2032, Driven by Ri …
The spinal cord stimulators market is set for substantial growth, propelled by the increasing prevalence of chronic pain conditions such as failed back surgery syndrome, complex regional pain syndrome, and neuropathic pain. Growing demand for minimally invasive neuromodulation therapies, coupled with advancements in rechargeable and wireless systems, is enhancing patient outcomes and long-term therapy adherence.
Innovative technologies, including closed-loop stimulation, high-frequency and burst stimulation, and MRI-compatible devices, are driving wider…
Nuclear Imaging Equipment Market to Register a CAGR of 4.96% by 2032, Driven by …
The nuclear imaging equipment market is poised for substantial growth, fueled by the increasing prevalence of cancer and cardiovascular diseases, the growing demand for precision diagnostics, and advancements in hybrid imaging technologies such as PET/CT, PET/MRI, and SPECT/CT. Digital innovations, including time-of-flight PET and CZT-based detectors, are improving image resolution, scan speed, and quantitative accuracy, enhancing both clinical outcomes and patient experience.
Additionally, the adoption of AI-enabled imaging workflows, automation,…
More Releases for Human
Defending Human Life
Albert Covarrubias, Jr was fighting for his Constitutional rights and was killed in the line of duty by his own police force. There is no divine right to kill him for simply standing up for his rights. Every person has the right to stand for what they believe, rather than be gunned down. You cannot take away human life as being ok with simply saying it was a mistake.
If someone…
I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern…
The Human Whisperer
'The Human Whisperer'
Finlay McArthur
Published in Austin Macauley Publishers Ltd on 30th of June 2020, both in paperback and eBook version.
The Human Whisperer is the second book by Finlay on his quest to give his readers a better understanding of life. This book will help the reader understand that as humans, there is so much more to us than we think. We are connected to the world both physically and…
Human Physiology 2019
Human Physiology 2019
Theme: Exploring the Principles of Physiology & Metabolism
September 16-17, 2019 | London, United Kingdom
Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
